There is nothing more fulfilling (or is it just filling? 🥟🥡) than a truly #multinational 🇭🇰🇸🇬🇯🇵🇺🇸 #multidisciplinary #MDT before heading out to the airport as we ‘digest’ new knowledge acquired and say goodbye to #ASCO25. Molly Li Hidehito HORINOUCHI Yuji Uehara, MD Stephanie Saw

#ASCO25 most enjoyable one so far! Delighted to present our research, plan collabs and most importantly celebrate milestones with friends. Discussing data with people real-time in the congress beats listening online any day. Now time to combat jet lag 😵‍💫

Thrilled the first chrono-immunotherapy RCT from #ASCO25 validates our JTO & JTO CRR paper: ICI infusions after 3 PM worsened outcomes in Stage III NSCLC. Fantastic to see a daring idea move so quickly to a positive RCT! jtocrr.org/article/S2666-… #LCSM

Honored to have recently served as a peer reviewer for both Nature Medicine and Nature Communications. It's a privilege to get an early look at the forefront of scientific discovery.

ASCO25 にて当科の上原悠治(@dryujiuehara)、小山隆文らがポスター発表を行いました。日本のC-CAT (国立がん研究センターがんゲノム情報管理センター（C-CAT）)に登録されたNSCLC患者2966人のデータを基に、臨床試験参加に関わる臨床病理学的・ゲノム的因子と臨床試験と予後 (全生存期間,

Going to Japan for work is another level of 生きがい. Many thanks to 特定非営利活動法人 日本肺癌学会 for inviting me to speak at the preceptorship programme and Hidehito HORINOUCHI for hosting me. A pleasure to meet old friends and learn from new young enthusiastic ones too. 次回を楽しみにしています 😊

Great to speak on "AI in Oncology" at the Japanese Lung Cancer Society's Preceptorship Program 2025 特定非営利活動法人 日本肺癌学会 ! Meaningful discussions on AI's potential in cancer care & research. Excited to explore more possibilities for AI in oncology. #LCSM

Huge thanks to Stephanie Stephanie Saw for her inspiring and informative talk with young lung oncologists in Japan! Her dedication and mentorship are truly impressive to me. This global collaboration and friendship are what I love about #LCSM

Oncologist Near Me – Razelle Kurzrock (Razelle Kurzrock, MD): Revolutionizing Cancer Treatment Through Precision Medicine MD Anderson Cancer Center | Medical College of Wisconsin oncodaily.com/oncolibrary/on… #Cancer #CureMatch #CureMetrix #OncoDaily #OncologistNearMe #Oncology #MedEd #MedX

📊Just in: The 2024 Journal Impact Factors (JIF) are out! 👨‍💻A look at the top 50 journals for Oncology and Respiratory Medicine.

【7/24（木）18:00〜オンライン説明会・進路相談会開催！】 当科の佐藤潤医師・上原悠治Yuji Uehara, MD 医師が働き方やキャリアなどを丁寧にご説明します。興味やご経歴に応じた先生との個別相談も可能。初期研修医・専攻医の方大歓迎ですのでぜひお気軽にご参加ください。 x.gd/EMU81

「第7回 早期新薬開発試験 トランスレーショナルリサーチワークショップ」を2025年10月5日(日)に開催します。がん新薬の早期開発に関する最新知見（PDX, オルガノイド等のTR研究）や国内外の取り組み(米国、英国、香港 )を学ぶ集中講座です。 ・日時: 2025年10月5日(日) 9:30～15:00 ・形式:

Congratulations to my friend Yuji Uehara, MD from 🇯🇵 for presenting at the oral abstract session - Day 2 #ESMOTATAsia25 in HK. From an initial meeting on Twitter to IRL at 日本臨床腫瘍学会（JSMO） earlier this year! ESMO - Eur. Oncology

Honored to receive a merit travel grant and deliver an oral presentation at this exceptionally well-organized meeting. The food has been excellent too! 🙏 ✨ESMO - Eur. Oncology #ESMOTATAsia25

8/14（木）元バイエル会長である栄木 憲和氏をお招きして「ドラッグロスの真の問題点〜日米の薬事・薬価制度の理解を深める〜」というテーマで講演会を開催します。会の終了後、質疑応答ができる時間を設けていますので、ぜひご意見交換の場としてご活用ください。 forms.gle/WKPTnRZfNHRCHg…

Exciting news! 🎉 My abstract has been accepted for a Poster presentation at #ESMO25 in Berlin, October. Looking forward to sharing my work and connecting globally. See you there! ESMO - Eur. Oncology 国立がん研究センター中央病院 先端医療科

A fantastic conference with exceptional talk, hospitality, food, and invaluable global networking opportunities in Hong Kong🇭🇰. #ESMOTATAsia25 The growing importance of Asian collaboration is evident. I'm looking forward to joining next year's event! ESMO - Eur. Oncology

とても良い制度だと思います！しかし、採択率の低い雑誌のピアレビューが依頼されるどうか？はEditorの知り合いかどうかが大きいので、この制度が広まると、より国際的なネットワークを築くことを意識していかないと、日本から良い雑誌に通すのは、より難しくなっていくと感じます。

DNA copy number variation is strongly buffered at the protein level. The buffering is much stronger than at the RNA level.

A fascinating and legitimate concern: routine AI use lead to skill loss. Eendoscopists' ability without AI fell after regular AI implementation. But AI is the new "PC" or "IT"—we're already reliant on it. What does this "deskilling" mean for the future of medicine?🤔